Article
Rethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring.
Journal of infection in developing countries - 19 Oct 2012
Habbal Wafa, Monem Fawza
Abstract excerpt
INTRODUCTION: Hepatitis B virus patients are usually treated in Syria with alpha interferon and nucleos(t)ide analogues. Genotypic viral factors causing inadequate response or relapse following initial response are not routinely investigated. This study aimed to explore and discuss local therapeutic decisions from a molecular perspective. METHODOLOGY: Fifty patients with hepatitis B from Syria were tested for HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
